Ena Respiratory

Showing 3 posts of 3 posts found.

ENA Respiratory doses first patients with INNA-051 antiviral nasal spray

February 17, 2026
Ear Nose & throat, Ena Respiratory

ENA Respiratory, a clinical-stage biopharmaceutical company specialising in the prevention of viral respiratory infections, has announced the first dosing of …

ENA Respiratory appoints two strategic advisors to support leading project

May 7, 2025
Research and Development Ena Respiratory, Infections and infestations, Respirology, strategic adivsors

ENA Respiratory, focused on minimising the impact of viral respiratory infections, has announced the appointment of Kenny Simmen (pictured left) …

nasal-spray-drawing

Novel prophylactic nasal spray reduced COVID-19 replication by 96% in animal studies

September 28, 2020
Research and Development, Sales and Marketing COVID-19, Ena Respiratory, Nasal Spray

Australian biotech Ena Respiratory has revealed new data demonstrating that its novel nasal spray almost halted replication of the SARS-CoV-2 …

The Gateway to Local Adoption Series

Latest content